Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
64 results:

  • 1. Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
    Hao J; Liu C; Gu Z; Yang X; Lan X; Guo X
    Nat Commun; 2024 Apr; 15(1):2820. PubMed ID: 38561332
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Precursor exhausted CD8
    Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
    Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The New Role of
    Zhang X; Wu T; Qin R; Cai X; Zhou Y; Wang X; Shang Z; Li G; Yang R; Dong C; Li J; Ren Y; Ding R; Li Y
    Front Biosci (Landmark Ed); 2023 Nov; 28(11):301. PubMed ID: 38062804
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
    Yakou MH; Ghilas S; Tran K; Liao Y; Afshar-Sterle S; Kumari A; Schmid K; Dijkstra C; Inguanti C; Ostrouska S; Wilcox J; Smith M; Parathan P; Allam A; Xue HH; Belz GT; Mariadason JM; Behren A; Drummond GR; Ruscher R; Williams DS; Pal B; Shi W; Ernst M; Raghu D; Mielke LA
    Sci Immunol; 2023 Oct; 8(88):eadf2163. PubMed ID: 37801516
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway.
    Zhuang Y; Ning C; Liu P; Zhao Y; Li Y; Ma Z; Shan L; Piao Y; Zhao P; Jin X
    Oncol Res; 2022; 30(6):289-300. PubMed ID: 37303493
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. hnf1a regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
    Xia R; Hu C; Ye Y; Zhang X; Li T; He R; Zheng S; Wen X; Chen R
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36825600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Concurrent inactivating mutations and expression losses of RGS2, hnf1a, and CAPN12 candidate tumor suppressor genes in colon cancers.
    Kim JW; Moon SW; Mo HY; Son HJ; Choi EJ; Yoo NJ; Ann CH; Lee SH
    Pathol Res Pract; 2023 Jan; 241():154288. PubMed ID: 36566600
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. m
    Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. hnf1a-AS1: A Tumor-associated Long Non-coding RNA.
    Liu Y; Zhao F; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
    Curr Pharm Des; 2022; 28(21):1720-1729. PubMed ID: 35619319
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
    Larsen PT; Jørgensen SF; Njor SH
    BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High Diversity of Glycosphingolipid Glycans of colorectal cancer Cell Lines Reflects the Cellular Differentiation Phenotype.
    Wang D; Madunić K; Zhang T; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
    Mol Cell Proteomics; 2022 Jun; 21(6):100239. PubMed ID: 35489554
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer.
    Xu Y; Wang H; Wang T; Chen C; Sun R; Yao W; Ma Y; Zhang Q; Wu L; Zeng S; Sun X
    Cancer Sci; 2022 May; 113(5):1739-1751. PubMed ID: 35238098
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Differential expression of hnf1a and hnf1a-AS1 in colon cancer cells.
    Sepehri Z; Banerjee A; Vizeacoumar FS; Freywald A; Vizeacoumar FJ; Dolinsky VW; Davie JR
    IUBMB Life; 2022 Jun; 74(6):496-507. PubMed ID: 35184384
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatocyte nuclear factor hnf1a is a potential regulator in shaping the super-enhancer landscape in colorectal cancer liver metastasis.
    Cai C; Bi D; Bick G; Wei Q; Liu H; Lu L; Zhang X; Qin H
    FEBS Lett; 2021 Dec; 595(24):3056-3071. PubMed ID: 34719039
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. hnf1a regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
    Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
    Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
    Michael M; Liauw W; McLachlan SA; Link E; Matera A; Thompson M; Jefford M; Hicks RJ; Cullinane C; Hatzimihalis A; Campbell IG; Rowley S; Beale PJ; Karapetis CS; Price T; Burge ME
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):39-52. PubMed ID: 33755789
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Wnt-β-catenin activation epigenetically reprograms T
    Quandt J; Arnovitz S; Haghi L; Woehlk J; Mohsin A; Okoreeh M; Mathur PS; Emmanuel AO; Osman A; Krishnan M; Morin SB; Pearson AT; Sweis RF; Pekow J; Weber CR; Khazaie K; Gounari F
    Nat Immunol; 2021 Apr; 22(4):471-484. PubMed ID: 33664518
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
    Chandra S; Srinivasan S; Batra J
    Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
    Moe K; Maa HC; Pei D; Liang YJ; Chen YL
    Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Slow-Cycling cancer Stem Cells Regulate Progression and Chemoresistance in Colon cancer.
    Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
    Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.